Schroder Investment Management Group
INBX

Schroder Investment Management Group’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Schroder Investment Management Group’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-131,295
Closed -$4.99M – 1267
2023
Q4 		$4.99M Sell
131,295
-106,148
-45% -$2.27M 0.01% 760
2023
Q3 		$4.36M Sell
237,443
-83,946
-26% -$1.76M 0.01% 775
2023
Q2 		$8.34M Hold
321,389
– – 0.01% 676
2023
Q1 		$6.06M Sell
321,389
-53,686
-14% -$1.25M 0.01% 739
2022
Q4 		$9.24M Sell
375,075
-89,215
-19% -$2.62M 0.01% 649
2022
Q3 		$8.33M Buy
464,290
+182,961
+65% +$3.3M 0.01% 658
2022
Q2 		$3.37M Buy
281,329
+5,763
+2% +$84.8K 0.01% 875
2022
Q1 		$6.16M Buy
275,566
+158,397
+135% +$4.04M 0.01% 787
2021
Q4 		$5.12M Buy
117,169
+24,506
+26% +$980K 0.01% 756
2021
Q3 		$3.09M Buy
+92,663
New +$2.82M ﹤0.01% 885

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Schroder Investment Management Group's INBX Position: Q1 2024 in Review

Schroder Investment Management Group sold out of Inhibrx, Inc. Common Stock (INBX) in Q1 2024, closing a stake of 131,295 shares — an estimated $4.99M sold.

Schroder Investment Management Group first reported a position in INBX in Q3 2021 and held it in 10 quarters. The position peaked at $9.24M in Q4 2022. 126 funds tracked by Wall St. Rank hold INBX as of Q1 2024.

  • Schroder Investment Management Group reported no remaining Inhibrx, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Schroder Investment Management Group sold 131,295 Inhibrx, Inc. Common Stock shares in Q1 2024, an estimated $4.99M.
  • Schroder Investment Management Group first reported a position in Inhibrx, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
  • Schroder Investment Management Group's Inhibrx, Inc. Common Stock position peaked at $9.24M in Q4 2022.
  • 126 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q1 2024.

Based on Schroder Investment Management Group's 13F filing for Q1 2024, filed 14 May 2024.